Delivery Order SPE2DB20D3101-SPE2DB25FRVV5
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a 60-count package, with a ceiling value of $17,181.16 and a completion date of September 23, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,590.58 by the Defense Logistics Agency on August 27, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a firm fixed price delivery order with a completion date of September 18, 2025, and represents a non-set-aside competitive award. The contract will be fulfilled at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $8,590.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ofev 150 mg capsules (60-count units) with performance in Conshohocken, Pennsylvania. This non-set-aside contract was awarded on October 24, 2025, with an ultimate completion date of November 17, 2025. The delivery order represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $8.59K to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a firm fixed-price delivery order with a completion deadline of November 21, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $51,662.58 on August 13, 2025, for the supply of Ofev 100 mg capsules (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ofev 100 mg capsules (60-count units) valued at $8,630.28, with completion scheduled for August 27, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award involved...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $8,630.28. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to support federal medical procurement requirements. The order is scheduled for ultimate completion by October 16, 2025, and will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $8,630.28 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $8,630.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Ofev 100 mg capsules in quantities of 60 units. The contract, which is not set-aside and competitively awarded, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 17, 2025. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVV5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for Ofev, a specialty medication in the company's pharmaceutical portfolio, reflects AmerisourceBergen's ongoing role as a key supplier within the DLA's medical supply chain supporting Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 9/18/25 |